Similar articles for PMID: 15763644

Year	Number of Results
1989	1
1990	1
1993	1
1994	2
1995	3
1996	1
1997	1
1998	3
1999	1
2001	1
2002	2
2003	1
2004	1
2005	12
2006	21
2007	11
2008	11
2009	4
2011	1
2017	1
2024	0

1

Effects of tamoxifen and octreotide LAR on the IGF-system compared with tamoxifen monotherapy.

Helle SI, Mietlowski W, Guastalla JP, Szakolczai I, Bajetta E, Sommer H, Baltali E, Pinter T, Csepreghy M, Ottestad L, Boni C, Bryce C, Klijn JG, Lønning PE. Helle SI, et al. Eur J Cancer. 2005 Mar;41(5):694-701. doi: 10.1016/j.ejca.2004.12.015. Epub 2005 Jan 21. Eur J Cancer. 2005. PMID: 15763644 Clinical Trial.

2

Effects of tamoxifen on insulin-like growth factors, IGF binding proteins and IGFBP-3 proteolysis in breast cancer patients.

Grønbaek H, Tanos V, Meirow D, Peretz T, Raz I, Flyvbjerg A. Grønbaek H, et al. Anticancer Res. 2003 May-Jun;23(3C):2815-20. Anticancer Res. 2003. PMID: 12926118

3

A randomized, multicenter prospective trial assessing long-acting release octreotide pamoate plus tamoxifen as a first line therapy for advanced breast carcinoma.

Bajetta E, Procopio G, Ferrari L, Martinetti A, Zilembo N, Catena L, Alú M, Della TS, Alberti D, Buzzoni R. Bajetta E, et al. Cancer. 2002 Jan 15;94(2):299-304. doi: 10.1002/cncr.10239. Cancer. 2002. PMID: 11900215 Free article. Clinical Trial.

4

Evaluation of continuous infusion suramin in metastatic breast cancer: impact on plasma levels of insulin-like growth factors (IGFs) and IGF-binding proteins.

Lawrence JB, Conover CA, Haddad TC, Ingle JN, Reid JM, Ames MM, Suman VJ, Marks RS, Erlichman C, Hartmann LC. Lawrence JB, et al. Clin Cancer Res. 1997 Oct;3(10):1713-20. Clin Cancer Res. 1997. PMID: 9815555 Clinical Trial.

5

Randomized trial of tamoxifen versus combined tamoxifen and octreotide LAR Therapy in the adjuvant treatment of early-stage breast cancer in postmenopausal women: NCIC CTG MA.14.

Pritchard KI, Shepherd LE, Chapman JA, Norris BD, Cantin J, Goss PE, Dent SF, Walde D, Vandenberg TA, Findlay B, O'Reilly SE, Wilson CF, Han L, Piura E, Whelan TJ, Pollak MN. Pritchard KI, et al. J Clin Oncol. 2011 Oct 10;29(29):3869-76. doi: 10.1200/JCO.2010.33.7006. Epub 2011 Sep 12. J Clin Oncol. 2011. PMID: 21911723 Clinical Trial.

6

[A randomized, double-blind, placebo-controlled, phase 3 trial comparing SMS 201-995 pa LAR plus tamoxifen versus tamoxifen plus placebo in women with locally recurrent or metastatic breast cancer].

Sommer H, Pröhl-Steimer B, Bajetta E, Haus U, Janni W, Kay A. Sommer H, et al. Zentralbl Gynakol. 2001 Oct;123(10):557-61. doi: 10.1055/s-2001-19088. Zentralbl Gynakol. 2001. PMID: 11753809 Clinical Trial. German.

7

Serum IGF-I, IGFBP-3, and matrix metalloproteinase-7 levels and acquired chemo-resistance in advanced colorectal cancer.

Gallego R, Codony-Servat J, García-Albéniz X, Carcereny E, Longarón R, Oliveras A, Tosca M, Augé JM, Gascón P, Maurel J. Gallego R, et al. Endocr Relat Cancer. 2009 Mar;16(1):311-7. doi: 10.1677/ERC-08-0250. Epub 2008 Dec 24. Endocr Relat Cancer. 2009. PMID: 19109398

8

An ER activity profile including ER, PR, Bcl-2 and IGF-IR may have potential as selection criterion for letrozole or tamoxifen treatment of patients with advanced breast cancer.

Henriksen KL, Rasmussen BB, Lykkesfeldt AE, Møller S, Ejlertsen B, Mouridsen HT. Henriksen KL, et al. Acta Oncol. 2009;48(4):522-31. doi: 10.1080/02841860802676383. Acta Oncol. 2009. PMID: 19173092

9

Effects of hormone replacement therapy on insulin-like growth factor (IGF)-I, IGF-II and IGF binding protein (IGFBP)-1 to IGFBP-4: implications for cardiovascular risk.

Heald A, Kaushal K, Anderson S, Redpath M, Durrington PN, Selby PL, Gibson MJ. Heald A, et al. Gynecol Endocrinol. 2005 Mar;20(3):176-82. doi: 10.1080/09513590400027406. Gynecol Endocrinol. 2005. PMID: 16019358 Clinical Trial.

10

Serum levels of IGF-1 and IGFBP-3 during adjuvant chemotherapy for primary breast cancer.

Fürstenberger G, Senn E, Morant R, Bolliger B, Senn HJ. Fürstenberger G, et al. Breast. 2006 Feb;15(1):64-8. doi: 10.1016/j.breast.2005.04.009. Epub 2005 Jul 5. Breast. 2006. PMID: 15998587 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

73 results

Results by year